Az értekezés témakörében megjelent “in extenso” közlemények

9.3. Az értekezés témakörében megjelent “in extenso” közlemények

Ábrók M, Arcson Á, Lázár A, Urbán E, Deák J: Combination of selective enrichment and MALDI-TOF MS for rapid detection of Streptococcus agalactiae colonisation of pregnant women. J Microbiol Methods 2015;114:23-25.

Bálint A, Molnár T, Szűcs M, Farkas K, Urbán E, Nagy F, Szepes Z, Wittmann T: Clostridium difficile-infekció előfordulási gyakorisága a gyulladásos bélbetegségek relapszusa során - előzetes tanulmány. Magy Belorv Arch 2013;6:80-86.

Bartha NA, Sóki J, Urbán E, Nagy E: Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations. Int J Antimicrob Agents 2011;38:522-525.

Bogdan M, Peric L, Ördög K, Vukovic D, Urbán E, Sóki J: The first characterized carbapenem-resistant Bacteroides fragilis strain from Croatia and the case study for it. Acta Microbiol Immunol Hung 2018;65:317-323.

Brodszky V, Gulácsi L, Ludwig E, Prinz G, Banai J, Reményi P, Strbak B, Kertész A, Kopcsóné Németh I, Zsoldiné Urbán E, et al.: A Clostridium difficile-fertőzések antibiotikum-terápiája: A tudományos bizonyítékok szisztematikus áttekintése és metaanalízise. Orv Hetil 2013;154:23:890-899.

Eitel Z, Sóki J, Urbán E, Nagy E: The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobe 2013;21:43-49.

Fodor D, Ume KL, Matkó M, Nacsa E, Urbán E, Hajdú E: Clostridium difficile okozta akut gastroenteritis fertőzőosztályon. Orv Hetil 2012;153:1992-1997.

Gajdács M, Urbán E: Epidemiology and species distribution of anaerobic Gram-negative cocci: a 10-year retrospective survey (2008-2017). Acta Pharm Hung 2019;89:84-87.

Gajdács M, Urbán E: The relevance of anaerobic bacteria in brain abscesses: a ten-year retrospective analysis (2008-2017). Infect Dis 2019;10:779-781.

Gulácsi L, Kertész A; Kopcsóné Németh I, Banai J, Ludwig E, Prinz G, Reményi P, Strbák B, Zsoldiné Urbán E, Baji P. et al.: A Clostridium difficile-fertőzések epidemiológiája, betegségterhe és terápiája. Orv Hetil 2013;541188-1193.

Horváth B, Hunyadkürti J, Vörös A, Fekete Cs, Urbán E, Kemény L, Nagy I: Genome sequence of Propionibacterium acnes Type II Strain ATCC 11828. J Bacteriol 2012;194:202-203.

Hunyadkürti J, Feltóti Zs, Horváth B, Nagymihály M, Vörös A, McDowell A, Patrick S, Urbán E, Nagy I: Complete genome sequence of Propionibacterium acnes Type IB strain 6609. J Bacteriol 2011;193:4561-4562.

Leitsch D, Sóki J, Kolarich D, Urbán E, Nagy E: A study on nim expression in Bacteroides fragilis. Microbiology-SGM 2014;160:616-622.

Nagy E, Becker S, Sóki J, Urbán E, Kostrzewa M: Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time of-flight mass spectrometry. J Med Microbiol 2011;60:1584-1590.

Nagy E, Justesen US, Eitel Zs, Urbán E: Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates. Anaerobe 2015;31:65-71.

Nagy E, Sóki J, Edwards R, Urbán E, Lajos Z, Szabó B: Az első hazai carbapenemase termelésen alapuló imipenem rezisztens Bacteroides fragilis törzsek genetikai vizsgálata.

Infektológia És Klinikai Mikrobiológia 2000;7:65-66.

Nagy E, Sóki J, Urbán E, Szőke I, Fodor E, Edwards R: Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary. Acta Biol Hung 2001;52:271-280.

Nagy E, Urbán E, Jakab G, Szikra L, Miszti C, Szabó J: Humán patogén anaerob baktériumok in vitro érzékenysége tigecyclinre és a komparátor antibiotikumokra Magyarországon. Lege Artis Med 2009;19:593-601.

Nagy E, Urbán E, Sóki J, Terhes G, Nagy K: The place of molecular genetic methods in the diagnostics of human pathogenic anaerobic bacteria. Acta Microbiol Immunol Hung 2006;53:183-194.

Nagy E, Urbán E, Terhes G: Clostridium difficile által okozott hasmenés klinikai jelentősége, diagnosztikája, terápiája és megelőzése. Infekt Klin Mikrobiol 2007;14:7-12.

Nagy I, Pivarcsi A, Koreck A, Széll M, Urbán E, Kemény L: Distinct strains of Propionibacterium acnes induces selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors. J Invest Dermatol 2005;124:931-938.

Ördögh L, Hunyadkürti J, Vörös A, Horváth B, Szűcs A, Urbán E, Kereszt A, Kondorosi É, Nagy I: Complete genome sequence of Propionibacterium avidum strain 44067, isolated from a human skin abscess. Genome Announc 2013;1(3):e00337-13.

Sóki J, Eitel Z, Urbán E, Nagy E: Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey. Int J Antimicrob Agents 2013;41:122-125.

Sóki J, Gonzalez SM, Urbán E, Nagy E, Ayala JA: Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains. J Antimicrob Chemother 2011;66:2492-2500.

Sóki J, Hedberg M, Patrick S, Bálint B, Herczeg R, Nagy I, Hecht DW, Nagy E, Urbán E:

Emergence and evolution of an international cluster of MDR Bacteroides fragilis isolates J Antimicrob Chemother 2016;71:2441-2448.

Sóki J, Wareham DW, Rátkai Cs, Aduse-Opoku J, Urbán E, Nagy E: Prevalence, nucleotide sequence and expression studies of two proteins of a 5.6kb, Class III, Bacteroides plasmid frequently found in clinical isolates from European countries. Plasmid 2010;63:86-97.

Sóki J, Edwards R, Urbán E, Fodor E, Beer Z, Nagy E: Screening of isolates from faeces for carbapenem-resistant Bacteroides strains; existence of strains with novel types of resistance mechanisms. Int J Antimicrob Agents 2004;24:450-454.

Sóki J, Edwards R, Lajos Z, Vrabely T, Fodor E, Urbán E, Nagy E: Isolation and characterization of an imipenem-resistant Bacteroides fragilis strain from a prostate abscess in a dog. Vet Microbiol 2002;84:187-190.

Sóki J, Edwards R, Urbán E, Fodor E, Nagy E: A clinical isolate of Bacteroides fragilis from Hungary with high-level resistance to imipenem. J Med Microbiol 2001;(50):107.

Sóki J, Eitel Zs, Urbán E, Nagy E: Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey. Int J Antimicrob Agents 2013;41:122-125.

Sóki J, Fodor E, Hecht DW, Edwards R, Rotimi VO, Kerekes I, Urbán E, Nagy E: Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait. J Med Microbiol 2004;53:413-419.

Sóki J, Gal M, Brazier JS, Rotimi VO, Urbán E, Nagy E, Duerden BI: Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. J Antimicrob Chemother 2006;57:212-220.

Sóki J, Urbán E, Szőke I, Fodor E, Nagy E: Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary. J Med Microbiol 2000;49:427-430.

Toprak NU, Alida CMV, Urbán E, Wybo I, Justesen US, Jean-Pierre H, Morris T, Akgul O, Kulekci G, Soyletir G, Nagy E: Performance of mass spectrometric identification of clinical Prevotella species using the VITEK MS system: A prospective multi-center study. Anaerobe 2018;54:205-209.

Toprak NU, Veloo ACM, Urbán E, Wybo I, Justesen US, Jean-Pierre H, Morris T, Akgul O, Kulekci G, Soyletir G. et al.: A multicenter survey of antimicrobial susceptibility of Prevotella species as determined by Etest methodology. Anaerobe 2018;52:9-15.

Toprak NU, Veloo ACM, Urbán E, Wybo I, Jean-Pierre H, Morris T, Justesen US, Tripkovic V, Jeverica S, Soyletir G, Nagy E; ESCMID Study Group for Anaerobic Infections (ESGAI):

Comparing identification of clinically relevant Prevotella species by VITEK MS and MALDI biotyper. Acta Microbiol Immunol Hung. 2019 Dec 9:1-8. doi:

10.1556/030.66.2019.022. [Epub ahead of print]

Urbán E, Nagy E, Pál T, Sonnevend Á, Conlon JM: Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-AR-23) against anaerobic bacteria. Int J Antimicrob Agents 2007;29:317-321.

Urbán E: Five-year retrospective epidemiological survey of anaerobic bacteraemia in a university hospital and rewiew of the literature. Eur J Microbiol Immunol 2012;2:140-147.

Veloo ACM, Jean-Pierre H, Justesen US, Morris T, Urbán E, Wybo I, Kostrzewa M, Friedrich AW: Validation of a for anaerobic bacteria optimized MALDI-TOF MS biotyper database:

The ENRIA project. Anaerobe 2018;54:224-230.

Veloo ACM, Jean-Pierre H, Justesen US, Morris T, Urbán E, Wybo I, Kostrzewa M, Friedrich AW: An overview of the data obtained during the validation of an optimized MALDI-TOF MS Biotyper database for the identification of anaerobic bacteria. Data brief 2018;18:1484–

1496.

Veloo ACM, de Vries ED, Jean-Pierre H, Justesen US, Morris T, Urbán E, Wybo I, van Winkelhoff AJ: The optimization and validation of the Biotyper MALDI-TOF MS database for the identification of gram positive anaerobic cocci. Clin Microbiol Infect 2016;22:793-798.

Veloo ACM, Jean-Pierre H, Justesen US, Morris T, Urbán E, Wybo I, Shah HN, Friedrich AW: A multi-center ring trial for the identification of anaerobic bacteria using MALDI-TOF MS. Anaerobe 2017;48:94-97.